Government Notifies IT Rules Amendment 2026 Regulating AI-Generated Content and Deepfakes

The Central Government has notified the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Amendment Rules, 2026 through a Gazette notification dated 10 February 2026, introducing new regulations for AI-generated content, deepfakes, and synthetically generated information in India. A key feature of the amendment is the introduction of the concept of “synthetically generated information” […]
Read More

Delhi High Court Clarifies Maintainability of Patent Revocation Proceedings Post Expiry of Patent

The Delhi High Court, in Boehringer Ingelheim Pharma GmbH & Co. KG v. Controller of Patents & Anr., considered the maintainability of revocation proceedings under the Patents Act, 1970 in relation to a patent covering the pharmaceutical compound Linagliptin. The dispute arose from a revocation petition filed by Macleods Pharmaceuticals seeking revocation of the patent […]
Read More

Delhi High Court Examines Conflict Between Trademark Registration and Prior Use in “FIELD MARSHAL” Dispute

The Delhi High Court, in Thukral Mechanical Works v. PM Diesels Pvt. Ltd., held that prior user rights may prevail over statutory trademark registration, recognising the superior goodwill of PM Diesels Pvt. Ltd. in relation to the mark “FIELDMARSHAL” used for centrifugal pumps. The Court affirmed that a party that has built substantial reputation through […]
Read More

CCI Closes Complaint Against Eros International Concerning AI-Modified Re-Release of Film “Raanjhanaa”

The Competition Commission of India (CCI) has closed a complaint filed against Eros International Media Ltd. concerning the AI-modified re-release of the Hindi film Raanjhanaa. The informants had alleged that the re-release of a modified version of the film, reportedly incorporating an altered ending generated through artificial intelligence, was undertaken without the consent of the […]
Read More

Bombay High Court Grants Interim Injunction in Pharmaceutical Trademark Dispute Concerning “GLIMET”

The Bombay High Court granted interim relief in favour of Laboratories Griffon Pvt. Ltd. in Comm IP No. 213 of 2022, restraining the defendants from using the marks “GLYNET” and “GLYZET” in relation to pharmaceutical preparations for the treatment of diabetes. The plaintiffs are the registered proprietors of the trademarks “GLIMET” (Registration No. 579544) and […]
Read More

Delhi High Court Clarifies Scope of Section 16 of the Companies Act in Corporate Name Rectification Dispute

The Delhi High Court, in Refex Industries Limited v. Regional Director, Northern Region, Ministry of Corporate Affairs & Anr., set aside an order of the Regional Director dated August 23, 2018 rejecting the petitioner’s application filed under Section 16(1)(b) of the Companies Act, 2013. The petitioner, Refex Industries Limited, which was originally incorporated as Refex […]
Read More

DPIIT Issues Concept Note Proposing Amendments to the Designs Act, 2000

The Department for Promotion of Industry and Internal Trade (DPIIT) has released a concept note proposing amendments to the Designs Act, 2000. Issued on January 23, 2026, the concept note invites comments and suggestions from stakeholders within thirty days, with the objective of modernising India’s design protection framework and aligning it with evolving international practices. […]
Read More

Disclaimer

The website www.doddandco.com contains general information for the convenience of our clients and is not a source of advertising, solicitation of work, or legal advice.

By clicking the “Agree” button below, you accept that there has been no invitation, inducement, or personal communication by Dodd & Co. and its members to create an attorney-client relationship through this website.